
Asorin PM2 Tablet PR
Marketer
Fawn Incorporation
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Asorin PM2 Tablet PR
Diabetic patients can manage their blood glucose with Asorin PM2 Tablet PR, a dual-action medication. Used alongside diet and exercise, it enhances blood sugar regulation in adult type 2 diabetics by improving insulin effectiveness. Dosage and duration should strictly adhere to your physician's instructions; take it with food to minimize digestive discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; avoid doubling up. Excessive intake risks hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Renal function tests will be conducted before treatment commences. Limit alcohol consumption to mitigate potential side effects.
Uses of Asorin PM2 Tablet PR
Managing type 2 diabetes
Major Benefits of Asorin PM2 Tablet PR:
Follow your doctor's instructions or consult the product label for usage guidelines. Asorin PM2 Tablet PR should be administered with a meal.
Common Side effects of Asorin PM2 Tablet PR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Asorin PM2 Tablet PR:
Follow your doctor's instructions or consult the product label for dosage information. Take Asorin PM2 Tablet PR with a meal.
How Asorin PM2 Tablet PR works:
Asorin PM2 Tablet PR combines three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone, offering enhanced blood sugar management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances the body's sensitivity to insulin.
SAFETY ADVICE
AlcoholUNSAFE
Combining Asorin PM2 Tablet PR with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Asorin PM2 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Asorin PM2 Tablet PR while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Asorin PM2 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Asorin PM2 Tablet PR use. Consult your physician. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Asorin PM2 Tablet PR, potentially requiring dosage modification under medical supervision. Asorin PM2 Tablet PR is contraindicated for those with severe hepatic dysfunction.
What if you forget to take Asorin PM2 Tablet PR :
Should you forget a dose of Asorin PM2 Tablet PR, ingest it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Asorin PM2 Tablet PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
